Oral spray helps cannabis users cut back: study
Aussie trial finds first real-world evidence that nabiximols helps counter addiction
![Cannabis](https://www.ausdoc.com.au/wp-content/uploads/2022/08/Cannabis_smoker-2.jpg)
Patients with cannabis dependence may reduce their use of the illicit drug with the aid of the cannabis agonist nabiximols alongside CBT counselling, an Australian study shows.
A randomised placebo-controlled trial in NSW has found that patients using the oromucosal nabiximols spray, Sativex, reduce their number of days using illicit cannabis.